MARKETSHorizon Pharma Stock Goes Vertical After Positive Eye Disease Drug ResultsBy Scott Van VoorhisFeb 28, 2019 11:10 AM EST
PRESS RELEASESHorizon Therapeutics Plc Announces Redemption Of All $400 Million Of Its Exchangeable Senior NotesBy Business WireJun 3, 2020 8:05 AM EDT
PRESS RELEASESData Presented On KRYSTEXXA® (pegloticase Injection) Co-Prescribed With An Immunomodulator Adds To Growing Body Of Evidence For This Treatment ApproachBy Business WireJun 3, 2020 8:00 AM EDT
PRESS RELEASESHorizon Therapeutics Named Number One Best Workplace In ChicagoBy Business WireMay 21, 2020 9:15 AM EDT
PRESS RELEASESData On Multiple Immunomodulation Approaches With KRYSTEXXA® (pegloticase Injection) To Be Presented At The Annual European Congress Of Rheumatology (EULAR 2020)By Business WireMay 21, 2020 8:00 AM EDT
PRESS RELEASESNew Data On The Pharmacokinetic Profile Of TEPEZZA™ (teprotumumab-trbw) Reinforce The Labeled Dosing Regimen, Indicating A Positive, Consistent Response To TherapyBy Business WireMay 14, 2020 9:00 AM EDT
PRESS RELEASESU.S. Physician Survey Illustrates The Devastating Impact Of Thyroid Eye Disease On Patient Quality Of LifeBy Business WireMay 11, 2020 12:00 PM EDT
PRESS RELEASESHorizon Therapeutics Plc Announces Availability Of PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Oral Granules In Packets In The United StatesBy Business WireApr 27, 2020 8:10 AM EDT
PRESS RELEASESHorizon Therapeutics Plc To Release First-Quarter 2020 Financial Results And Host Webcast On May 6, 2020By Business WireApr 15, 2020 8:00 AM EDT
PRESS RELEASESTEPEZZA™ (teprotumumab-trbw) Significantly Reduces Proptosis (Eye Bulging), A Key Marker Of Thyroid Eye Disease, Across Patient SubtypesBy Business WireMar 31, 2020 12:00 PM EDT
PRESS RELEASESHorizon Therapeutics Plc Donates $1.5 Million To COVID-19 Response Efforts In Illinois And Other Impacted U.S. And Global CommunitiesBy Business WireMar 26, 2020 4:15 PM EDT
PRESS RELEASESHorizon And Willis Tower Elevate The Need For Rare Disease Innovation On Rare Disease DayBy Business WireFeb 28, 2020 10:00 AM EST
PRESS RELEASESHorizon Therapeutics Plc Partners With EveryLife Foundation To Establish $1 Million #RAREis Scholarship For Adults With Rare DiseasesBy Business WireFeb 28, 2020 8:00 AM EST
PRESS RELEASESHorizon Therapeutics Plc To Present At The Cowen And Company 40th Annual Health Care ConferenceBy Business WireFeb 18, 2020 8:30 AM EST
PRESS RELEASESHorizon Therapeutics Plc Announces U.S. FDA Approval Of New Dosage Form For PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Oral GranulesBy Business WireFeb 18, 2020 8:00 AM EST
PRESS RELEASESUplifting Athletes Announces Horizon Therapeutics Plc As Exclusive Sponsor To Help Tackle Rare Disease At The National Football League (NFL) Scouting CombineBy Business WireFeb 11, 2020 8:00 AM EST
PRESS RELEASESHorizon Therapeutics Plc To Release Fourth-Quarter And Full-Year 2019 Financial Results And Host Webcast On Feb. 26, 2020By Business WireFeb 4, 2020 8:00 AM EST
PRESS RELEASESHorizon Therapeutics Announces Significant Expansion And Relocation Of U.S. OperationsBy Business WireJan 28, 2020 11:10 AM EST
PRESS RELEASESHorizon Therapeutics Plc Announces Changes In Research And Development OrganizationBy Business WireJan 24, 2020 4:05 PM EST
PRESS RELEASESThe New England Journal Of Medicine Publishes Comprehensive Data From Phase 3 Clinical Trial (OPTIC) Of TEPEZZA™ (teprotumumab-trbw) For Thyroid Eye DiseaseBy Business WireJan 22, 2020 5:20 PM EST
PRESS RELEASESFDA Approves TEPEZZATM (teprotumumab-trbw) For The Treatment Of Thyroid Eye Disease (TED)By Business WireJan 21, 2020 3:04 PM EST
PRESS RELEASESHorizon Therapeutics Plc Increases Peak U.S. Annual Net Sales Expectations For Key Growth Drivers; Provides Update On Several Pipeline ProgramsBy Business WireJan 13, 2020 8:15 AM EST
PRESS RELEASESMIRROR Open-Label Study Topline Data Of Methotrexate With KRYSTEXXA (pegloticase Injection) Indicates Significant Improvement In Response RateBy Business WireJan 13, 2020 8:05 AM EST
MARKETSHorizon Pharma Stock Goes Vertical After Positive Eye Disease Drug ResultsBy Scott Van VoorhisFeb 28, 2019 11:10 AM EST
